Anika Therapeutics Inc (ANIK.OQ)
ANIK.OQ on NASDAQ Stock Exchange Global Select Market
24.32USD
4:00pm EDT
24.32USD
4:00pm EDT
Price Change (% chg)
$4.21 (+20.93%)
$4.21 (+20.93%)
Prev Close
$20.11
$20.11
Open
$23.52
$23.52
Day's High
$25.88
$25.88
Day's Low
$23.52
$23.52
Volume
130,510
130,510
Avg. Vol
28,510
28,510
52-wk High
$25.88
$25.88
52-wk Low
$9.13
$9.13
About
Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika’s wholly owned subsidiary, Anika... (more)
Overall
| Beta: | 1.53 |
| Market Cap (Mil.): | $281.46 |
| Shares Outstanding (Mil.): | 14.00 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ANIK.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.26 | 47.13 | 37.76 |
| EPS (TTM): | 1.04 | -- | -- |
| ROI: | 11.69 | -2.58 | 18.76 |
| ROE: | 13.69 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.58 | +0.41 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Bayer AG (BAYGn.DE) | €89.43 | +2.08 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

